Gilad Oren 4
4 · Aprea Therapeutics, Inc. · Filed Oct 24, 2024
Insider Transaction Report
Form 4
Gilad Oren
DirectorPresident/CEO
Transactions
- Purchase
Common Stock
2024-10-23$3.92/sh+500$1,958→ 333,395 total
Holdings
- 600(indirect: By Son)
Common Stock
- 1,200(indirect: By Daughter)
Common Stock
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.91 to $3.92, inclusive. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.